Quince Therapeutics (QNCX) Stock Chart & Stock Price History $1.71 -0.05 (-2.84%) (As of 12/24/2024 03:03 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Quince Therapeutics Stock Price Performance 5 Day Performance-3.93%1 Month Performance-15.35%3 Month Performance+118.87%6 Month Performance+143.76%Year-To-Date Performance+62.86%1 Year Performance+50.00% Receive QNCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. QNCX Stock Chart for Thursday, December, 26, 2024 QNCX Chart by TradingView Quince Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/25/2024$1.71$1.71$1.74$1.68141,555 shs$75.24 million12/24/2024$1.76$1.71-2.84%$1.74$1.68141,555 shs$75.24 million12/23/2024$1.78$1.76-1.12%$1.96$1.69142,351 shs$77.44 million12/20/2024$1.76$1.78+1.14%$1.85$1.74104,696 shs$78.32 million12/19/2024$1.85$1.76-4.86%$1.89$1.75179,455 shs$77.44 million12/18/2024$1.84$1.85+0.54%$2.00$1.84166,523 shs$81.40 million Get the Latest News and Ratings for QNCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/17/2024$1.91$1.84-3.66%$1.99$1.80203,840 shs$80.96 million12/16/2024$2.03$1.91-5.91%$2.06$1.84375,569 shs$84.04 million12/13/2024$2.04$2.03-0.49%$2.09$1.96185,867 shs$89.32 million12/12/2024$2.05$2.04-0.49%$2.07$2.0155,397 shs$89.76 million12/11/2024$1.97$2.05+4.06%$2.11$1.94184,980 shs$90.20 million12/10/2024$2.04$1.97-3.43%$2.15$1.91151,984 shs$86.68 million12/09/2024$2.10$2.04-2.86%$2.45$1.99464,812 shs$89.76 million12/06/2024$1.82$2.10+15.38%$2.17$1.76298,604 shs$92.40 million12/05/2024$2.00$1.82-9.00%$2.05$1.69564,132 shs$80.08 million12/04/2024$2.16$2.00-7.41%$2.14$1.98234,092 shs$88 million12/03/2024$2.08$2.16+3.85%$2.19$2.02227,493 shs$91.52 million12/02/2024$2.05$2.08+1.46%$2.15$1.96184,695 shs$91.52 million11/29/2024$2.04$2.05+0.49%$2.08$2.0058,641 shs$90.20 million11/28/2024$2.04$2.04$2.11$2.0295,284 shs$89.76 million11/27/2024$2.02$2.04+0.99%$2.11$2.0292,009 shs$89.76 million11/26/2024$1.98$2.02+2.02%$2.14$2.00295,061 shs$88.88 million11/25/2024$1.96$1.98+1.02%$2.21$1.95527,645 shs$87.12 million Related Companies Corvus Pharmaceuticals Stock Price Chart Procaps Group Stock Price Chart C4 Therapeutics Stock Price Chart Immutep Stock Price Chart COMPASS Pathways Stock Price Chart Atyr PHARMA Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Foghorn Therapeutics Stock Price Chart Candel Therapeutics Stock Price Chart Atea Pharmaceuticals Stock Price Chart Receive QNCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QNCX) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
